Molecular radiotherapy (MRT) has demonstrated unique therapeutic advantages in the
treatment of an increasing number of cancers. As with other treatment modalities, there is …

Rhenium-188 (188Re) is a high energy beta-emitting radioisotope with a short 16.9 h
physical half-life, which has been shown to be a very attractive candidate for use in …

Transarterial chemoembolization (TACE) is a form of intra-arterial catheter-based
chemotherapy that selectively delivers high doses of cytotoxic drug to the tumor bed …

Abstract BACKGROUND: Intrahepatic arterial yttrium 90 (90Y) microspheres have been
proposed as a less toxic, less invasive therapeutic option to transhepatic arterial …

Bone pain due to skeletal metastases constitutes the most common type of chronic pain
among patients with cancer. It significantly decreases the patient's quality of life and is …

Radionuclide therapy (RNT) based on the concept of delivering cytotoxic levels of radiation
to disease sites is one of the rapidly growing fields of nuclear medicine. Unlike conventional …

Liver malignancies, either primary tumours (mainly hepatocellular carcinoma and
cholangiocarcinoma) or secondary hepatic metastases, are a major cause of death, with an …

Theranostics in nuclear medicine refers to personalized patient management that involves
targeted therapy and diagnostic imaging using a single or combination of radionuclide (s) …

Rhenium-188 is one of the most readily available generator derived and useful
radionuclides for therapy emitting β-particles (2.12 MeV, 71.1% and 1.965 MeV, 25.6%) and …

In recent decades, the use of alpha; pure beta; or beta/gamma emitters in oncology,
endocrinology, and interventional cardiology rheumatology, has proved to be an important …